The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II expansion cohort in colorectal cancer to evaluate the safety and tolerability of RRx-001 blood mix.
 
George A. Fisher
Stock and Other Ownership Interests - Seagen (I)
Honoraria - Ipsen; Merck; Novartis
Consulting or Advisory Role - Genentech; Ipsen; Jounce Therapeutics; Merck; Taiho Pharmaceutical; TERUMO
Research Funding - Aduro Biotech (Inst); Forty seven (Inst); Genentech/Roche (Inst); Merck (Inst); Newlink Genetics (Inst)
Travel, Accommodations, Expenses - Merck; Merck/Genentech
Other Relationship - AstraZeneca; Celgene; CytomX Therapeutics; Silenseed
 
Scott Caroen
Employment - EpicentRx
Stock and Other Ownership Interests - EpicentRx
Patents, Royalties, Other Intellectual Property - Scott Caroen is on patents relating to EpicentRx, Inc., technologies.
 
Bryan Oronsky
Employment - EpicentRx
Leadership - EpicentRx; EpicentRx (I)
Stock and Other Ownership Interests - EpicentRx
Patents, Royalties, Other Intellectual Property - I am listed as a co-inventor of several technologies under EpicentRx. Inc.
 
Jeannie Williams
Employment - EpicentRx
 
Tony R. Reid
Employment - Epicentrx
Leadership - Epicentrx
Stock and Other Ownership Interests - Epicentrx
Honoraria - Genentech/Roche
Consulting or Advisory Role - Genentech/Roche
Speakers' Bureau - Genentech/Roche
Research Funding - Genentech/Roche
Patents, Royalties, Other Intellectual Property - Epicentrx licensed patented technology